We’d all like to age gracefully, but sometimes our bodies need a little help. If fine lines and wrinkles are bothering you, you may have started to consider cosmetic Botox. Botox is a drug made from a toxin that doctors often use in small doses to treat a variety of health problems. It can be used to treat eyelid spasms, eye muscle disorders and more.
Botox works by weakening certain muscles and nerves, and the effects last about three to four months for cosmetic uses. People often come in routinely to maintain their preferred appearance. Cosmetic Botox is a safe, FDA-approved treatment that smoothens fine lines and wrinkles in between the eyebrows, around the eyes, and on the forehead. The procedure takes about 10 minutes and results appear in 24 to 48 hours.
Ophthalmologists are actually the most experienced administrators of Botox. Because of their medical benefits, most ophthalmologists have been working frequently with Botox for years. Dr. Keith Carlson of Claris Eye Care & Surgery is no exception. As a Mayo Clinic-trained, board-certified ophthalmologist, Dr. Carlson has been working with Cosmetic Botox for over seven years, for both medical and cosmetic purposes. Dr. Carlson, who was named “Top Doc” by Minneapolis St. Paul Magazine, has completed extensive training in the field and is a trusted ophthalmologist in his community.
All of the Claris Eye Care & Surgery procedures are performed at the renowned Phillips Eye Institute next door. This ensures that the most cutting edge technology is used by the most experienced hands.
If the wrinkles on your face are getting in the way of your confidence, don’t wait any longer. It’s time to take control and feel like yourself again. If you are considering cosmetic Botox, the professionals at Claris can help you take that next step.
If you or a loved one is experiencing any symptoms of unwanted wrinkles, eye spasms or more, call us to learn more about how cosmetic Botox can help. Call with any of your questions: 612-775-8005, or email us.
Learn more about Claris: Facebook, Twitter and Google+.